Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07540611Not ApplicableNot Yet Recruiting

Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive

Role: lead

NCT06913075Not ApplicableNot Yet Recruiting

FET in Adenomyosis

Role: lead

NCT06911840Not Yet Recruiting

Male Factor Infertility Across India Using Aphrodite Criteria

Role: lead

NCT05716139Not ApplicableTerminated

Natural Cycle vs Programmed Cycle Frozen Embryo Transfer

Role: lead

NCT05802303Not ApplicableTerminated

Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation

Role: lead

All 5 trials loaded